NASDAQ:UNCY

Unicycive Therapeutics Stock Predictions

etoro logo Buy UNCY
*Your capital is at risk
$7.20
-0.0300 (-0.415%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

UNCY Prediction Chart

UNCY Predictions History

Latest community submissions for UNCY.
Predictor Target Session Target Price Result Direction Accuracy Score
May 14, 2026 $8.32 -2.28% $8.56 X 97.15% 0
May 14, 2026 $8.36 -1.82% $8.56 X 97.61% 0
May 14, 2026 $8.41 -1.14% $8.56 X 98.28% 0
May 14, 2026 Bullish $8.56 V 1
May 4, 2026 $7.48 -2.50% $7.98 X 93.71% 0
May 4, 2026 $7.52 -2.00% $7.98 X 94.19% 0
May 4, 2026 $7.57 -1.25% $7.98 X 94.91% 0
May 4, 2026 Bullish $7.98 V 1
Mar 5, 2026 $6.91 -2.23% $6.83 V 98.79% 2
Mar 5, 2026 $6.97 -1.39% $6.83 V 97.93% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for UNCY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT UNICYCIVE THERAPEUTICS, INC.
Unicycive Therapeutics
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE